Cerevel Therapeutics (CERE) Announces Warrant Redemption for Cash Exercise

Cerevel Therapeutics (Nasdaq: CERE), which completed their combination with ARYA Sciences Acquisition Corp. II in late October of 2020, announced this morning that it will be redeeming its outstanding public SPAC warrants for cash exercise.  The current price is around $13.34, but as of this writing, the warrants are up $0.019, which would bring it
Read More